Source: Benzinga

Boston Scientific: Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition

Boston Scientific topped Q1 revenue and EPS forecasts, lifted its 2025 outlook, and announced CFO Dan Brennan's retirement after nearly 30 years. read more

Read full article »
Boston Scientific's Competitors | Boston Scientific's News | Boston Scientific's Financials
Stay up-to-date with the latest news on Boston Scientific
Annual Revenue
$10-50B
Employees
50-100K
Michael F. Mahoney's photo - Chairman & CEO of Boston Scientific

Chairman & CEO

Michael F. Mahoney

CEO Approval Rating

75/100

Read more
Stay up-to-date with the latest news on Boston Scientific